Abstract | OBJECTIVE: METHODS: Serum sTREM-1 levels from 17 patients with limited cutaneous SSc (lSSc), 24 patients with diffuse cutaneous SSc (dSSc), and 29 healthy control individuals were examined by ELISA. RESULTS: Total SSc patients exhibited significantly elevated serum sTREM-1 levels relative to controls (p < 0.01). Serum sTREM-1 levels were significantly elevated in patients with dSSc compared to controls (p < 0.005) and lSSc patients (p < 0.05). By contrast, sTREM-1 levels in lSSc were similar to those in controls. Serum sTREM-1 levels were significantly elevated in SSc patients with decreased percentage vital capacity (%VC). Consistent with this, serum sTREM-1 levels in SSc patients correlated negatively with %VC (r = -0.24, p < 0.005). Among SSc patients with pulmonary fibrosis, sTREM-1 levels were significantly increased in patients with decreased %VC or decreased percentage of diffusion capacity for carbon monoxide relative to those with normal values (p < 0.05). CONCLUSION: Serum sTREM-1 levels were elevated in dSSc patients and correlated with severity of pulmonary fibrosis, suggesting that serum sTREM-1 is a novel serological marker for the disease severity of SSc.
|
Authors | Hajime Tomita, Fumihide Ogawa, Toshihide Hara, Koichi Yanaba, Yohei Iwata, Eiji Muroi, Ayumi Yoshizaki, Kazuhiro Komura, Motoi Takenaka, Kazuhiro Shimizu, Minoru Hasegawa, Manabu Fujimoto, Shinichi Sato |
Journal | The Journal of rheumatology
(J Rheumatol)
Vol. 37
Issue 4
Pg. 787-91
(Apr 2010)
ISSN: 0315-162X [Print] Canada |
PMID | 20156945
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biomarkers
- Membrane Glycoproteins
- Receptors, Immunologic
- TREM1 protein, human
- Triggering Receptor Expressed on Myeloid Cells-1
|
Topics |
- Adult
- Aged
- Biomarkers
(blood)
- Enzyme-Linked Immunosorbent Assay
- Female
- Humans
- Male
- Membrane Glycoproteins
(blood)
- Middle Aged
- Pulmonary Fibrosis
(blood, complications)
- Receptors, Immunologic
(blood)
- Scleroderma, Diffuse
(blood, complications)
- Scleroderma, Limited
(blood, complications)
- Severity of Illness Index
- Triggering Receptor Expressed on Myeloid Cells-1
|